학술논문
Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials
Document Type
Conference Paper
Author
Rizzardini, G.; Overton, E.T.; Orkin, C.; Swindells, S.; Arasteh, K.; Górgolas Hernández-Mora, M.; Pokrovsky, V.; Girard, P.-M.; Oka, S.; Andrade-Villanueva, J.F.; Richmond, G.J.; Baumgarten, A.; Masiá, M.; Latiff, G.; Griffith, S.; Harrington, C.M.; Hudson, K.J.; St. Clair, M.; Talarico, C.L.; Patel, P.; Cutrell, A.; D'Amico, R.; Mrus, J.M.; Smith, K.Y.; Spreen, W.R.; Margolis, D.A.; Van Eygen, V.; Vanveggel, S.; Van Solingen-Ristea, R.; Crauwels, H.; Wu, S.; Wills, A.; Ford, S.L.; Roberts, J.; Chow, K.; Walters, N.
Source
In: Journal of Acquired Immune Deficiency Syndromes . (Journal of Acquired Immune Deficiency Syndromes, 1 December 2020, 85(4):498-506)
Subject
Language
English
ISSN
10779450
15254135
15254135